FDA approves first oral medication for Ulcerative Colitis Vinay Singh singh1 Jun 2018 7:20 PM ISTThe Food and Drug Administration (FDA) approved Xeljanz (Signal Transducers and Activators of Transcription) to treat adults with moderate to severely...
Baricitinib -New Treatment for Moderate to severe RA Vinay Singh singh4 Jun 2018 7:30 PM ISTU.S. Food and Drug Administration (FDA) has approved the 2-mg dose of OLUMIANT®(baricitinib), a once-daily oral medication for the treatment of adults...
Topical JAK Inhibitor - Future treatment for Alopecia Areata Vinay Singh singh13 July 2018 7:05 PM ISTU.S. Food and Drug Administration (FDA) has granted Fast Track designation to an investigational topical Janus Kinase (JAK) 1/3 inhibitor, ATI-502 for...
New drug effective for treatment of rheumatoid arthritis-The Lancet Vinay Singh singh24 Aug 2018 8:10 PM ISTA new drug was found safe and effective in treating patients with moderate to severe forms of rheumatoid arthritis who have shown an inadequate...
FDA approves Upadacitinib for Moderate to Severe Rheumatoid Arthritis Deepanjana Sarkar20 Aug 2019 7:15 PM ISTFood and Drug Administration has approved JAK Kinase Inhibitor Drug, Upadacitinib for Moderate to Severe Rheumatoid Arthritis.The U.S. Food and Drug...
